World’s Top 50 Innovators 2022

Information

Codex is proud to host the World’s Top 50 Innovators 2022.

A distinguished line up of scientists, engineers, entrepreneurs and visionaries who are moving the world forward with the power of their technologies and ideas will convene to share their excitement with you.

The format will be a series of Codex Talks, each of which is a concise presentation, lasting 15 minutes (or less), in which the speaker addresses a challenging question faced by their technology or industry today, and ends with a bold prediction for the future.

The pace of change is accelerating and what was once science fiction is becoming reality. Come and join us to learn what’s on the horizon, understand the bigger picture, and future-proof your business. Entrepreneurs and innovators from all the industries of the future will be there to fire your imagination..!

Don’t miss one of the most prestigious events in the technology calendar.

Codex events are where the big hitters come out to play.

Play video

Wellcome Collection, 183 Euston Road, London NW1 2BE, United Kingdom

26 September 2022 - 28 September 2022

8:00 am - 6:00 pm

Schedule

8:00 am 8:40 am Registration

9:00 am 10:30 am Robotics

Speaker 1
Speaker 2
Speaker 3
Speaker 4

Q&A

10:30 am 11:00 am Morning Coffee

11:00 am 12:15 pm Robotics

Andrew Bate, CEO, SwarmFarm Robotics; Jocie Bate, Co-Founder
Speaker 6
Speaker 7

Q&A

12:15 pm 1:00 pm LUNCH

1:15 pm 2:45 pm Artificial Intelligence

Alex Zhavoronkov, CEO, Insilico Medicine
Greg Cross, CEO, Soul Machines
Speaker 10
Speaker 11

Q&A

2:45 pm 3:15 pm Afternoon Tea

3:15 pm 5:15 pm Future of Mobility

Doron Myersdorf, CEO, StoreDot
How can Extreme Fast Charging technology accelerate the adoption rate of electric vehicles?
Michael O’Kronley, CEO, Ascend Elements
Speaker 14
Speaker 15
Speaker 16
Speaker 17

Q&A

5:15 pm 6:00 pm Drinks Reception

Speakers

Dr. Douglas Terrier
Chief Technologist, NASA

Dr. Douglas Terrier serves as chief technologist and is the senior leader of the office. In this role, Terrier is the agency’s principal advisor and advocate on NASA technology policy and programs, helping plot the strategic direction of the agency’s space technology program.

Terrier is responsible for the operation, management and programs within the Office of the Chief Technologist. The Office of the Chief Technologist serves as the NASA Administrator’s principal advisor and advocate on matters concerning agency-wide technology policy. Terrier directs the work of the strategic integration and innovation teams, coordinating and tracking technology investments across the agency, working to infuse technologies into future NASA missions and facilitating agency technology governance. He also is responsible for coordination and integration of research and development planning, policies and programs with other NASA Directorates and Offices, NASA centers and other government agencies, industry and academia. In addition, Terrier conducts advocacy activities with technology partners in industry, the educational community, the public, customers, and stakeholders.

Prior to his current position, Terrier worked at NASA’s Johnson Space Center, Houston, as the center’s chief technologist, serving as the principal advisor to the Center Director for technology, and the Center point of contact for the Agency Chief Technologist and the Space Technology Mission Directorate. He is responsible for guiding JSC’s technology investment strategy and integrating and managing the comprehensive technology portfolio.

Terrier also served as the deputy director of NASA Johnson’s Strategic Opportunity and Partnership Development (SOPD) Office. SOPD is responsible for guiding JSC future business including: strategic planning; new business pursuit; technology investment and commercialization; and partnership development. SOPD coordinates all external competitive pursuits and collaborative efforts on behalf of the Center technical Directorates.

Terrier’s previous assignment was Associate Director of Engineering where he led teams responsible for design and development of spacecraft for NASA’s human space exploration program. He also managed the multi-center Crew Exploration Vehicle Aero-science Project developing the critical aerodynamic and aero-thermal environment design database for the Orion spacecraft.

Prior to joining JSC, Terrier served in the Enterprise Readiness Division in the Office of Program Analysis and Evaluation at NASA HQ where he led efforts to align field Center institutions with the Vision for Space Exploration. He joined NASA in 2003 at the Langley Research Center in the Office of Business Development where he was responsible for growing and realigning the Center’s strategic business profile.

Terrier worked in the commercial aerospace sector for a total of 23 years with Lockheed Martin, General Dynamics and General Electric Aircraft Engines. He was responsible for International Business Development for Lockheed Martin in the Asia/Pacific region, supporting major successful campaigns including the Australian Joint Strike Fighter campaign worth $12B and the Singapore F-16 Peace Carvin Program worth $4B. Terrier managed Lockheed Martin’s Executive Strategy Team in their successful bid for the DoD’s Joint Strike Fighter program worth $500B.

As an engineering project manager for the Lockheed Martin, Terrier led several highly successful Department of Defense development projects on flight programs including: The F-35 Joint Strike Fighter international variants and block upgrade program; F-22 Raptor fighter program; A-12 Lightning program; National Aerospace Plane; and several classified programs.

Terrier earned a Ph.D. in aerospace engineering and a MS in Mechanical Engineering from the University of Texas. He also completed the Carnegie Mellon Graduate School of Industrial Management program with the Lockheed Martin Institute for Leadership Excellence. Terrier holds patents for his work in aerospace propulsion and has published numerous technical papers. He has earned the Lockheed Martin “Outstanding Technical Achievement” award on four occasions, several NASA “Superior Technical Accomplishment” awards, and the NASA Leadership medal.

Terrier is the proud father of two daughters and a son. In his spare time, he is an avid soccer player and an aircraft owner and pilot.
Dr. Albert Bourla
Chairman and CEO, Pfizer

As Chairman and Chief Executive Officer, Albert Bourla leads Pfizer in its purpose: Breakthroughs that change patients’ lives, with a focus on driving the scientific and commercial innovation needed to have a transformational impact on human health.

During his more than 25 years at Pfizer, Albert has built a diverse and successful career, holding a number of senior global positions across a range of markets and disciplines. Prior to taking the reins as CEO in January 2019, Albert served as the Pfizer’s Chief Operating Officer (COO) beginning in January 2018, responsible for overseeing the Company’s commercial strategy, manufacturing, and global product development functions.

Previously, from February 2016 to December 2017, Albert served as Group President of
Pfizer Innovative Health, which comprised the Consumer Healthcare, Inflammation & Immunology, Internal Medicine, Oncology, Rare Disease and Vaccines business groups. In addition, he created the Patient and Health Impact Group, dedicated to developing solutions for increasing patient access, demonstrating the value of Pfizer’s medicines, and ensuring broader business model innovation.

From January 2014 to January 2016, Albert served as Group President of Pfizer’s Global Vaccines, Oncology, and Consumer Healthcare business, where he was instrumental in building a strong and competitive position in Oncology and expanding the Company’s leadership in Vaccines.

Albert was President and General Manager of Pfizer’s Established Products business from 2010- 2013, leading the development and implementation of strategies and tactics related to Pfizer’s off- patent portfolio, (including legacy brands and generics.

He began his Pfizer career in 1993 in the Animal Health Division as Technical Director of Greece. He held positions of increasing responsibility within Animal Health across Europe, before moving to Pfizer’s New York Global Headquarters in 2001. From there, Albert went on to assume a succession of leadership roles within the Animal Health Division, including US Group Marketing Director (2001- 2004), Vice President of Business Development and New Products Marketing (2004-2006), and Area President of Animal Health Europe, Africa and the Middle East (2006-2009). In 2009, he assumed additional responsibilities for the Asia and Pacific regions.

Albert is a Doctor of Veterinary Medicine and holds a Ph.D. in the Biotechnology of Reproduction from the Veterinary School of Aristotle University. In 2020, he was ranked as America’s top CEO in the Pharmaceuticals sector by Institutional Investor magazine. He is on the executive committee of The Partnership for New York City, a vice president of the International Federation of Pharmaceutical Manufacturers & Associations, a director on multiple boards – Pfizer, Inc., The Pfizer Foundation, PhRMA, and Catalyst – and a Trustee of the United States Council for International Business. In addition, Albert is a member of the Business Roundtable and the Business Council.
Andrew Bate
CEO, SwarmFarm Robotics
Jocie Bate
Co-Founder, SwarmFarm Robitcs

Doron Myersdorf
CEO, StoreDot

Technology

StoreDot is a pioneer and leader of extreme fast charging (XFC) batteries that overcome the critical barrier to mainstream EV adoption – range and charging anxiety. The company has revolutionized the conventional Li-ion battery by designing and synthesizing proprietary organic and inorganic compounds, making it possible to charge an EV in just five minutes – the same time it takes to refuel a conventional combustion engine vehicle.

Biography

Doron Myersdorf co-founded StoreDot in 2012 with the mission to develop extreme fast charging (XFC) battery technology utilizing nano-scale metalloids and proprietary compounds to overcome a major barrier to electric vehicle adoption – range and charging anxiety. Prior to founding StoreDot, he served as Senior Director of SanDisk SSD Business Unit establishing and managing the division in Israel, building product strategy, marketing and business development, resulting in sales to leading laptop makers amounting to over $100M in revenue in under three years. Previously, he was VP Flash and Operations of msystems, a flash memory global leader, where he managed strategic sourcing of $1B annually, resulting in annual revenue of over $1.5B.

Myersdorf’s diverse record also includes being the Founder and CEO of InnerPresence, a Silicon Valley security software company, and Co-founder and VP Business Development of Siftology, a pioneer in interactive media search. Earlier, as a Partner at Tefen – Semiconductor Operations Management, he managed West Coast US Operations, in charge of the design and setup of over 40 semiconductor, pharmaceutical and biotech manufacturing facilities worldwide. Doron holds a PhD in R&D Management (1994), a MSc in Information Systems (cum laude, 1991) and a BSc in Industrial Engineering Management (cum laude, 1989), all from Technion – Israel Institute of Technology.
Michael O'Kronley
CEO, Ascend Elements

Technology

Based in Westborough, Mass., Ascend Elements is revolutionizing the production of lithium-ion battery materials by establishing a clean and sustainable supply chain using recycled feedstock. Its patented Hydro-to-Cathode™ technology directly synthesizes new cathode active materials from spent lithium-ion cells more efficiently than traditional methods, resulting in reduced cost, improved performance, and lowered GHG emissions. With fewer batteries going to landfill and a cleaner manufacturing process, Ascend Elements is taking the lithium-ion battery industry to a higher level with a truly sustainable, closed-loop battery economy.

Biography

Michael O’Kronley was named CEO of Ascend Elements in March 2020 and has served on the company’s board since 2017. Before Ascend Elements, he was Head of Corporate Strategy at A123 Systems. He has worked in the automotive and EV battery industries for over 25 years with previous business development, operations and engineering roles at Metaldyne Corp. and Robert Bosch. He holds bachelor’s and master’s degrees in Engineering from the University of Michigan.
Laurence Pearce
CEO, Lifelite
Mark Kotter
CEO, Bit Bio

Maarten Bosch
CEO, Mosa Meat
Martin Stephan
Deputy CEO, Carbios
Tadeu Carneiro
Chairman and CEO, Boston Metal

Technology

Boston Metal is commercializing breakthrough technology to electrify the steel industry with the potential to eliminate 10% of global carbon emissions. The company’s patented molten oxide electrolysis (MOE) platform replaces fossil fuels with renewable electricity to convert all iron ore grades into high-purity liquid metal through a cost-efficient, one-step process.

There are zero carbon emissions or harmful byproducts released during the process, only oxygen. With a highly modular and scalable solution, Boston Metal is enabling steel producers to meet growing global demand for low-cost, green steel while creating more economic opportunities across the steel value chain. Backed by leading investors and led by a world class team of scientists and metals industry veterans, Boston Metal is the only company with a direct, scalable approach to green the most important engineering material in the world.

Biography

Tadeu has over 40 years of metals industry experience, with expertise in global strategy, technology development, and customer-focused growth. As CEO of CBMM (80% market share for niobium) he grew revenue from $100M to over $2B and led a global program that saw the niobium market increase by more than eightfold. At Boston Metal, Tadeu has overseen two oversubscribed funding rounds and team growth from single digits to 80+ employees.

A metallurgical engineer, Tadeu is the lead independent director at Ivanhoe Mines (copper, zinc, nickel, and platinum group metals) and is an invited lecturer at the Department of Materials Science and Engineering at MIT. He recently accepted a seat on the advisory board of the Brigham and Women’s Hospital Heart and Vascular Center in Boston, MA.
Alex Zhavoronkov
CEO, Insilico Medicine

Greg Cross
CEO, Soul Machines

Speakers

Dr. Albert Bourla
Chairman and CEO, Pfizer

As Chairman and Chief Executive Officer, Albert Bourla leads Pfizer in its purpose: Breakthroughs that change patients’ lives, with a focus on driving the scientific and commercial innovation needed to have a transformational impact on human health.

During his more than 25 years at Pfizer, Albert has built a diverse and successful career, holding a number of senior global positions across a range of markets and disciplines. Prior to taking the reins as CEO in January 2019, Albert served as the Pfizer’s Chief Operating Officer (COO) beginning in January 2018, responsible for overseeing the Company’s commercial strategy, manufacturing, and global product development functions.

Previously, from February 2016 to December 2017, Albert served as Group President of Pfizer Innovative Health, which comprised the Consumer Healthcare, Inflammation & Immunology, Internal Medicine, Oncology, Rare Disease and Vaccines business groups. In addition, he created the Patient and Health Impact Group, dedicated to developing solutions for increasing patient access, demonstrating the value of Pfizer’s medicines, and ensuring broader business model innovation.

From January 2014 to January 2016, Albert served as Group President of Pfizer’s Global Vaccines, Oncology, and Consumer Healthcare business, where he was instrumental in building a strong and competitive position in Oncology and expanding the Company’s leadership in Vaccines.

Albert was President and General Manager of Pfizer’s Established Products business from 2010- 2013, leading the development and implementation of strategies and tactics related to Pfizer’s off- patent portfolio, (including legacy brands and generics.

He began his Pfizer career in 1993 in the Animal Health Division as Technical Director of Greece. He held positions of increasing responsibility within Animal Health across Europe, before moving to Pfizer’s New York Global Headquarters in 2001. From there, Albert went on to assume a succession of leadership roles within the Animal Health Division, including US Group Marketing Director (2001- 2004), Vice President of Business Development and New Products Marketing (2004-2006), and Area President of Animal Health Europe, Africa and the Middle East (2006-2009). In 2009, he assumed additional responsibilities for the Asia and Pacific regions.

Albert is a Doctor of Veterinary Medicine and holds a Ph.D. in the Biotechnology of Reproduction from the Veterinary School of Aristotle University. In 2020, he was ranked as America’s top CEO in the Pharmaceuticals sector by Institutional Investor magazine. He is on the executive committee of The Partnership for New York City, a vice president of the International Federation of Pharmaceutical Manufacturers & Associations, a director on multiple boards – Pfizer, Inc., The Pfizer Foundation, PhRMA, and Catalyst – and a Trustee of the United States Council for International Business. In addition, Albert is a member of the Business Roundtable and the Business Council.
Dr. Douglas Terrier
Chief Technologist, NASA

Dr. Douglas Terrier serves as chief technologist and is the senior leader of the office. In this role, Terrier is the agency’s principal advisor and advocate on NASA technology policy and programs, helping plot the strategic direction of the agency’s space technology program.

Terrier is responsible for the operation, management and programs within the Office of the Chief Technologist. The Office of the Chief Technologist serves as the NASA Administrator’s principal advisor and advocate on matters concerning agency-wide technology policy. Terrier directs the work of the strategic integration and innovation teams, coordinating and tracking technology investments across the agency, working to infuse technologies into future NASA missions and facilitating agency technology governance. He also is responsible for coordination and integration of research and development planning, policies and programs with other NASA Directorates and Offices, NASA centers and other government agencies, industry and academia. In addition, Terrier conducts advocacy activities with technology partners in industry, the educational community, the public, customers, and stakeholders.

Prior to his current position, Terrier worked at NASA’s Johnson Space Center, Houston, as the center’s chief technologist, serving as the principal advisor to the Center Director for technology, and the Center point of contact for the Agency Chief Technologist and the Space Technology Mission Directorate. He is responsible for guiding JSC’s technology investment strategy and integrating and managing the comprehensive technology portfolio.

Terrier also served as the deputy director of NASA Johnson’s Strategic Opportunity and Partnership Development (SOPD) Office. SOPD is responsible for guiding JSC future business including: strategic planning; new business pursuit; technology investment and commercialization; and partnership development. SOPD coordinates all external competitive pursuits and collaborative efforts on behalf of the Center technical Directorates.

Terrier’s previous assignment was Associate Director of Engineering where he led teams responsible for design and development of spacecraft for NASA’s human space exploration program. He also managed the multi-center Crew Exploration Vehicle Aero-science Project developing the critical aerodynamic and aero-thermal environment design database for the Orion spacecraft.

Prior to joining JSC, Terrier served in the Enterprise Readiness Division in the Office of Program Analysis and Evaluation at NASA HQ where he led efforts to align field Center institutions with the Vision for Space Exploration. He joined NASA in 2003 at the Langley Research Center in the Office of Business Development where he was responsible for growing and realigning the Center’s strategic business profile.

Terrier worked in the commercial aerospace sector for a total of 23 years with Lockheed Martin, General Dynamics and General Electric Aircraft Engines. He was responsible for International Business Development for Lockheed Martin in the Asia/Pacific region, supporting major successful campaigns including the Australian Joint Strike Fighter campaign worth $12B and the Singapore F-16 Peace Carvin Program worth $4B. Terrier managed Lockheed Martin’s Executive Strategy Team in their successful bid for the DoD’s Joint Strike Fighter program worth $500B.

As an engineering project manager for the Lockheed Martin, Terrier led several highly successful Department of Defense development projects on flight programs including: The F-35 Joint Strike Fighter international variants and block upgrade program; F-22 Raptor fighter program; A-12 Lightning program; National Aerospace Plane; and several classified programs.

Terrier earned a Ph.D. in aerospace engineering and a MS in Mechanical Engineering from the University of Texas. He also completed the Carnegie Mellon Graduate School of Industrial Management program with the Lockheed Martin Institute for Leadership Excellence. Terrier holds patents for his work in aerospace propulsion and has published numerous technical papers. He has earned the Lockheed Martin “Outstanding Technical Achievement” award on four occasions, several NASA “Superior Technical Accomplishment” awards, and the NASA Leadership medal.

Terrier is the proud father of two daughters and a son. In his spare time, he is an avid soccer player and an aircraft owner and pilot.
Laurence Pearce
CEO, Lifelite
Mark Kotter
CEO, Bit Bio

Martin Stephan
Deputy CEO, Carbios

Technology

Carbios is the first and only company in the world developing biological processes for the end-of-life of plastics and synthetic fibers with the potential to engage the entire industry in a truly circular economy. The company is now moving to industrialization with two disruptive innovations, of which a process to infinitely recycle PET without any quality loss, opening the possibility to create a virtuous circular economy scheme.

Biography

Martin joined Carbios in February 2017. He is now Deputy CEO of the Company. Martin has made his entire career in the chemical industry. Prior to joining Carbios, he held several senior international positions at Du Pont de Nemours, Chemours, and at the chemical branch of the French Oil & Gaz major, Total. He worked in France, Germany, Italy and in Switzerland, where he is currently resident.

Martin Stephan holds a Master in Business Economics from HEC in Paris and a BA in Economics from Paris II University.
Tadeu Carneiro
Chairman and CEO, Boston Metal

Technology

Boston Metal is commercializing breakthrough technology to electrify the steel industry with the potential to eliminate 10% of global carbon emissions. The company’s patented molten oxide electrolysis (MOE) platform replaces fossil fuels with renewable electricity to convert all iron ore grades into high-purity liquid metal through a cost-efficient, one-step process.

There are zero carbon emissions or harmful byproducts released during the process, only oxygen. With a highly modular and scalable solution, Boston Metal is enabling steel producers to meet growing global demand for low-cost, green steel while creating more economic opportunities across the steel value chain. Backed by leading investors and led by a world class team of scientists and metals industry veterans, Boston Metal is the only company with a direct, scalable approach to green the most important engineering material in the world.

Biography

Tadeu has over 40 years of metals industry experience, with expertise in global strategy, technology development, and customer-focused growth. As CEO of CBMM (80% market share for niobium) he grew revenue from $100M to over $2B and led a global program that saw the niobium market increase by more than eightfold. At Boston Metal, Tadeu has overseen two oversubscribed funding rounds and team growth from single digits to 80+ employees.

A metallurgical engineer, Tadeu is the lead independent director at Ivanhoe Mines (copper, zinc, nickel, and platinum group metals) and is an invited lecturer at the Department of Materials Science and Engineering at MIT. He recently accepted a seat on the advisory board of the Brigham and Women’s Hospital Heart and Vascular Center in Boston, MA.
Maarten Bosch
CEO, Mosa Meat

World’s Top 50 Innovators 2022

Information

TIME

PRICE

Schedule

Speakers

PRICE

Schedule

Speakers

PRICE

Schedule

Sponsors